Skip to main content

Table 1 Clinicopathological characteristics and tumor biomarker score according to microsatellite status.

From: Microsatellite instability in colorectal cancer and association with thymidylate synthase and dihydropyrimidine dehydrogenase expression

 

MSI*

n = 43

MSS*

n = 268

P

 

No.

(%)

No.

(%)

 

Gender

     

   Male

21

(49)

138

(51)

0.9

   Female

22

(51)

130

(49)

 

Age

     

   <70

28

(65)

217

(81)

0.02

   ≥70

15

(35)

51

(19)

 

Tumor site

     

   Proximal colon

36

(84)

68

(25)

0.001

   Distal colon

6

(14)

145

(54)

 

   Rectum

1

(2)

55

(21)

 

Stage

     

   II

6

(14)

26

(10)

0.4

   III

34

(79)

210

(78)

 

   IV

3

(7)

32

(12)

 

Differentiation grade (WHO)

     

   Well

5

(12)

88

(33)

0.001

   Intermediate

7

(16)

121

(45)

 

   Poor

31

(72)

59

(22)

 

Perineural tumor invasion

     

   +

5

(12)

53

(20)

0.5

   -

19

(44)

137

(51)

 

   not assessed

19

(44)

78

(29)

 

Vascular tumor invasion

     

   V0

18

(42)

142

(53)

0.8

   V1

8

(19)

58

(22)

 

   Vx

17

(39)

68

(25)

 

Intestinal perforation at resection

     

   yes

2

(5)

29

(11)

0.2

   no

41

(95)

239

(89)

 

Bowel obstruction before resection

     

   yes

1

(2)

44

(16)

0.01

   no

42

(98)

224

(84)

 

Thymidylate synthase level

     

   Low

12

(28)

218

(81)

0.001

   High

30

(70)

47

(18)

 

   not assessed

1

(2)

3

(1)

 

Dihydropyrimidine dehydrogenase level

     

   Low

21

(49)

163

(61)

0.1

   High

21

(49)

97

(36)

 

   not assessed

1

(2)

8

(3)

 
  1. *instable (MSI) or stable (MSS) microsatellites